ライフサイエンスコーパス: methicillin-resistant S. aureus

1 obactam for P. aeruginosa and vancomycin for methicillin-resistant S. aureus).

2 methicillin-sensitive S. aureus) and RN450M (methicillin-resistant S. aureus).

3 wn CF pathogens, including P. aeruginosa and methicillin-resistant S. aureus.

4 al cellulitis caused by community-associated methicillin-resistant S. aureus.

5 enged with virulent methicillin-sensitive or methicillin-resistant S. aureus.

6 eus infections, particularly those involving methicillin-resistant S. aureus.

7 ion of the antibiotic-resistant phenotype in methicillin-resistant S. aureus.

8 was able to rapidly and accurately diagnose methicillin-resistant S. aureus.

9 load within the lungs of rats infected with methicillin-resistant S. aureus.

10 of which is complicated by the emergence of methicillin-resistant S. aureus.

11 stinguishable from that of hospital-acquired methicillin-resistant S. aureus.

12 ibiotic susceptibility of community-acquired methicillin-resistant S. aureus.

13 e toxin 1, in both methicillin-sensitive and methicillin-resistant S. aureus.

14 ed bacteremia, right-sided endocarditis, and methicillin-resistant S. aureus.

15 lure in 2 patients with osteomyelitis due to methicillin-resistant S. aureus.

16 nt of nosocomial pneumonia in the absence of methicillin-resistant S. aureus.

17 l when there is extranasal colonization with methicillin-resistant S. aureus.

18 ratitis mediated by methicillin-sensitive or methicillin-resistant S. aureus.

19 e patients (15%) (4 Staphylococcus aureus [3 methicillin-resistant S. aureus], 2 Stenotrophomonas mal

20 hylococcus aureus (11.5% vs 0.8%, P < .001); methicillin-resistant S. aureus (6.9% vs 0%, P = .003);

21 the clinical cure rates in ME patients with methicillin-resistant S. aureus ABSSSIs were 142 of 152

22 In methicillin-resistant S. aureus, addition of oxacillin d

23 e groups of BALB/c mice were inoculated with methicillin-resistant S. aureus American Type Culture Co

24 cultures demonstrated that identification of methicillin resistant S. aureus and vancomycin resistant

25 Of the 165 isolates, 117 were methicillin-resistant S. aureus and 48 were methicillin-

26 tant, prompting hospital-based screening for methicillin-resistant S. aureus and implementation of bo

27 and was similar for those participants with methicillin-resistant S. aureus and methicillin-sensitiv

28 d peritoneal macrophage phagocytosis of both methicillin-resistant S. aureus and methicillin-sensitiv

29 gainst early and mature biofilms produced by methicillin-resistant S. aureus and methicillin-suscepti

30 cific, and reproducible for the detection of methicillin-resistant S. aureus and yields complete resu

31 ty against extended-spectrum beta-lactamase, methicillin-resistant S. aureus, and carbapenem-resistan

32 of S. caprae, emphasize its similarities to methicillin-resistant S. aureus, and demonstrate its abi

33 ltidrug-resistant bacteria, Candida species, methicillin-resistant S. aureus, and P. aeruginosa would

34 al, hematologic, or hepatic), infection with methicillin-resistant S. aureus, and TTPs of </=12 h wer

35 organisms predominate, whereas anaerobes and methicillin-resistant S. aureus are significant predicto

36 addition, multidrug-resistant organisms like methicillin-resistant S.aureus are spreading from health

37 nds, including cephalosporins active against methicillin-resistant S. aureus, are in preclinical deve

38 surveillance culture can accurately exclude methicillin-resistant S. aureus as an etiology in most p

39 itivity (0.32; 95% CI, 0.20-0.48) to predict methicillin-resistant S. aureus-associated infections, w

40 ty/specificity of colonization in predicting methicillin-resistant S. aureus-associated infections.

41 ne fourth of patients who are colonized with methicillin-resistant S. aureus at admission to the ICU.

42 ients, 5.8-8.3% of patients are colonized by methicillin-resistant S. aureus at admission, with a sig

43 he mechanisms by which S. aureus - including methicillin-resistant S. aureus - avoids neutrophil-medi

44 spectively enrolled patients with persistent methicillin-resistant S. aureus bacteremia (PB) and reso

45 tant S. aureus bacteremia (PB) and resolving methicillin-resistant S. aureus bacteremia (RB) matched

46 aureus isolate occurred during treatment of methicillin-resistant S. aureus bacteremia and probable

47 esistant S. aureus infection and eliminating methicillin-resistant S. aureus bacteremia in the ICU wi

48 over the last 5 years, not a single case of methicillin-resistant S. aureus bacteremia was observed.

49 MIC) has been shown to affect the outcome of methicillin-resistant S. aureus bacteremia, and recent d

50 Moreover, with community-associated methicillin-resistant S. aureus (CA MRSA) in a mouse mod

51 The dominant community-associated methicillin-resistant S. aureus (CA-MRSA) clone, USA300,

52 Community-associated methicillin-resistant S. aureus (CA-MRSA) is the most co

53 sent in almost all USA300 community-acquired methicillin-resistant S. aureus (CA-MRSA) isolates.

54 ty to vancomycin in the community-associated methicillin-resistant S. aureus (CA-MRSA) strain FPR3757

55 In community-associated methicillin-resistant S. aureus (CA-MRSA) strain MW2, no

56 isolates of S. aureus, community-associated methicillin-resistant S. aureus (CA-MRSA) USA300 secrete

57 a DeltahysA mutant of a community-associated methicillin-resistant S. aureus (CA-MRSA) USA300 strain

58 ar peptides produced by community-associated methicillin-resistant S. aureus (CA-MRSA) with homology

59 iologically linked with community-associated methicillin-resistant S. aureus (CA-MRSA), has frequentl

60 to the USA-300 group of community-associated methicillin-resistant S. aureus (CA-MRSA).

61 t S. aureus (HA-MRSA) and community-acquired methicillin-resistant S. aureus (CA-MRSA).

62 the rapid emergence of community-associated methicillin-resistant S. aureus (CA-MRSA).

63 received aerophages prior to ventilation and methicillin-resistant S. aureus challenge showed a highe

64 Methicillin-resistant S. aureus clinical specimens were

65 6538, Listeria monocytogenes ATCC 13932 and methicillin-resistant S. aureus clinical strains.

66 fected with Staphylococcus aureus, including methicillin-resistant S. aureus, clinical success was se

67 rial control and survival from influenza and methicillin-resistant S. aureus coinfection, despite a d

68 us aureus (hVISA) among clinical isolates of methicillin-resistant S. aureus collected from three hos

69 The sensitivity and specificity of prior methicillin-resistant S. aureus colonization as a predic

70 In our study, prior methicillin-resistant S. aureus colonization as ascertai

71 ator-associated pneumonia and 54 (13.9%) had methicillin-resistant S. aureus colonization documented

72 f once weekly active surveillance culture of methicillin-resistant S. aureus colonization in predicti

73 Methicillin-resistant S. aureus colonization is associat

74 A significant per year increase in methicillin-resistant S. aureus colonization was also no

75 there has been an increase in the number of methicillin-resistant S. aureus community-acquired infec

76 onia and may decrease the need for empirical methicillin-resistant S. aureus coverage in patients wit

77 rulence of the emerging community-associated methicillin-resistant S. aureus depends on phenol-solubl

78 As the burden of community-acquired methicillin-resistant S. aureus disease continues to inc

79 isolates of interest including MDROs such as methicillin-resistant S. aureus, extended-spectrum beta-

80 s able to rapidly identify and differentiate methicillin-resistant S. aureus from methicillin-suscept

81 select chronic diseases had infections with methicillin-resistant S. aureus, fungal infections, Pseu

82 cus aureus (MRSA) strains: hospital-acquired methicillin resistant S. aureus (HA-MRSA) and community-

83 s aureus (CA-MRSA) and healthcare-associated methicillin-resistant S. aureus (HA-MRSA) strains and th

84 Methicillin-resistant S. aureus had the highest mortalit

85 gence and rapid spread of community-acquired methicillin-resistant S. aureus has prompted a change in

86 epidemiology and clinical manifestations of methicillin-resistant S. aureus have undergone important

87 s also changing with some community-acquired methicillin-resistant S. aureus having resistance patter

88 vanDx, Woburn, MA, USA) for the detection of methicillin-resistant S. aureus in positive blood cultur

89 hat received aerophage prophylaxis had fewer methicillin-resistant S. aureus in the lungs compared wi

90 itially inappropriate antibiotic therapy for methicillin-resistant S. aureus increases the risk for m

91 g bacterial burdens and improved survival of methicillin-resistant S. aureus infected rats, underscor

92 tive strategy for reducing the prevalence of methicillin-resistant S. aureus infection and eliminatin

93 f associated infections during ICU stay, and methicillin-resistant S. aureus infection develops in on

94 The prevalence of methicillin-resistant S. aureus infection fell from 2.66

95 jects were followed for the development of a methicillin-resistant S. aureus infection for 60 days or

96 r tuning the innate immune response to treat methicillin-resistant S. aureus infection in immunodefic

97 strategies could decrease the prevalence of methicillin-resistant S. aureus infection in the ICU, wi

98 lonization who are at very elevated risk for methicillin-resistant S. aureus infection.

99 ranofin was efficacious in a murine model of methicillin-resistant S. aureus infection.

100 In studies that included only methicillin-resistant S aureus infections (n = 7232), th

101 es are justified by associated reductions in methicillin-resistant S aureus infections and improvemen

102 In 17,738 evaluable patients, methicillin-resistant S. aureus infections (4.1%; 95% CI

103 tent use of beta-lactam antibiotics to treat methicillin-resistant S. aureus infections may contribut

104 Methicillin-resistant S. aureus infections occurred in s

105 techniques might reduce the burden of severe methicillin-resistant S. aureus infections.

106 by drug-resistant strains, designated MRSA (methicillin-resistant S. aureus), is associated with fai

107 The culture of pus yielded a methicillin-resistant S. aureus isolate and the molecula

108 ain LAC, a well-studied community-associated methicillin-resistant S. aureus isolate.

109 y, we found that 56% of surveyed bloodstream methicillin-resistant S. aureus isolates (n = 148) at ou

110 h a set of 59 methicillin-susceptible and 44 methicillin-resistant S. aureus isolates from community-

111 Methicillin-resistant S. aureus isolates in this study s

112 rulent methicillin-susceptible S. aureus and methicillin-resistant S. aureus isolates now circulating

113 usceptible Staphylococcus aureus, 4/15 (27%) methicillin-resistant S. aureus isolates, 3/16 (19%) met

114 96% of the S. aureus isolates including all methicillin-resistant S. aureus isolates.

115 ed the toxicity and adhesiveness of 90 MRSA (methicillin resistant S. aureus) isolates and found that

116 With the epidemic spread of methicillin-resistant S. aureus, many cases of staphyloc

117 organisms, both 0.25 microg/mL) than against methicillin-resistant S. aureus (MIC(50) and MIC(90), bo

118 We report that methicillin resistant S. aureus (MRSA) is sensitized to

119 illinase resistant ss-lactams (methicillin), methicillin resistant S. aureus (MRSA) strains were iden

120 ections associated with S. aureus, including methicillin resistant S. aureus (MRSA).

121 Methicillin-resistant S aureus (MRSA) accounted for 4 of

122 and 142 cases (13.2%) of the infections were methicillin-resistant S aureus (MRSA).

123 A total of 39% of patients with methicillin-resistant S. aureus (MRSA) (n = 860) and 23%

124 The regional rate of methicillin-resistant S. aureus (MRSA) abscesses may ref

125 icillin-sensitive S. aureus (MSSA), 207 were methicillin-resistant S. aureus (MRSA) and 27 were borde

126 t-extremity junction (MREJ) region among 907 methicillin-resistant S. aureus (MRSA) and 900 methicill

127 ential as a single or combined treatment for methicillin-resistant S. aureus (MRSA) and anthrax infec

128 115 and E. coli O157:H7), clinical isolates (methicillin-resistant S. aureus (MRSA) and Candida albic

129 SSA), only one dimer was more potent against methicillin-resistant S. aureus (MRSA) and glycopeptide-

130 ns related to virulence was explored in both methicillin-resistant S. aureus (MRSA) and methicillin-s

131 te signal count ratio (GSCR), differentiated methicillin-resistant S. aureus (MRSA) and methicillin-s

132 f skin infection to compare the virulence of methicillin-resistant S. aureus (MRSA) and methicillin-s

133 and set7) of 61 well-characterized clinical methicillin-resistant S. aureus (MRSA) and methicillin-s

134 Among methicillin-resistant S. aureus (MRSA) and methicillin-s

135 ed with CAP, we calculated the prevalence of methicillin-resistant S. aureus (MRSA) and methicillin-s

136 cal presentations and outcomes of lukF-PV(+) methicillin-resistant S. aureus (MRSA) and MSSA SSTIs we

137 e bacterium Staphylococcus aureus, including methicillin-resistant S. aureus (MRSA) and vancomycin-re

138 nd Prevention (CDC) and others reported that methicillin-resistant S. aureus (MRSA) are significant c

139 A high incidence of methicillin-resistant S. aureus (MRSA) bacteremia cases

140 eptible S. aureus (MSSA) and 875 episodes of methicillin-resistant S. aureus (MRSA) bacteremia, with

141 reenings were done in parallel for 485 saved methicillin-resistant S. aureus (MRSA) blood isolates ac

142 hicillin-susceptible S. aureus (MSSA) and HO methicillin-resistant S. aureus (MRSA) BSIs for 2009-201

143 We determined the surface proteome of methicillin-resistant S. aureus (MRSA) clone usa300 deri

144 thwest Pacific clone [a community-associated methicillin-resistant S. aureus (MRSA) clone], and conte

145 While the prevalence of methicillin-resistant S. aureus (MRSA) continues to incr

146 explored whether whole-genome maps (WGMs) of methicillin-resistant S. aureus (MRSA) could be used to

147 methicillin-susceptible S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA) from 300 positive

148 mpared recovery of Staphylococcus aureus and methicillin-resistant S. aureus (MRSA) from nasal and gr

149 were infected with an isolate of the USA300 methicillin-resistant S. aureus (MRSA) genetic backgroun

150 nly two cases of empyema necessitatis due to methicillin-resistant S. aureus (MRSA) have been reporte

151 Virulent strains of methicillin-resistant S. aureus (MRSA) have emerged in t

152 ic basis of agr dysfunction among nosocomial methicillin-resistant S. aureus (MRSA) in an area of MRS

153 llin-sensitive S. aureus, with expansion for methicillin-resistant S. aureus (MRSA) in cases of cellu

154 ed B and T cell-dependent protection against methicillin-resistant S. aureus (MRSA) in mice.

155 ole in Staphylococcus aureus (S. aureus) and methicillin-resistant S. aureus (MRSA) induced peritonit

156 Although methicillin-resistant S. aureus (MRSA) infection has bec

157 that are used or their ability to eliminate methicillin-resistant S. aureus (MRSA) infection.

158 7 cells compared with nondiabetic mice after methicillin-resistant S. aureus (MRSA) infection.

159 Staphylococcus aureus (COSA) infections and methicillin-resistant S. aureus (MRSA) infections in 4 C

160 associated with epidemic community-acquired methicillin-resistant S. aureus (MRSA) infections, displ

161 usceptible S. aureus (MSSA) and 73 (17%) had methicillin-resistant S. aureus (MRSA) infections.

162 le (TMP-SMZ) is an alternative treatment for methicillin-resistant S. aureus (MRSA) infections.

163 a multinational collection of isolates from methicillin-resistant S. aureus (MRSA) infective endocar

164 Methicillin-resistant S. aureus (MRSA) is a leading heal

165 Methicillin-resistant S. aureus (MRSA) is a potential bl

166 an S. aureus infection were infected with a methicillin-resistant S. aureus (MRSA) isolate.

167 Three methicillin-resistant S. aureus (MRSA) isolates each had

168 susceptible Staphylococcus aureus (MSSA) and methicillin-resistant S. aureus (MRSA) isolates recovere

169 evalent clone of 12 geographically dispersed methicillin-resistant S. aureus (MRSA) isolates was iden

170 All 44 (49%) methicillin-resistant S. aureus (MRSA) isolates were fro

171 1 December 2006), performed SCCmec typing of methicillin-resistant S. aureus (MRSA) isolates, and str

172 t 250 S. aureus strains tested including 120 methicillin-resistant S. aureus (MRSA) isolates.

173 MLVA did not differentiate community methicillin-resistant S. aureus (MRSA) lineages (USA300,

174 Vancomycin failed to reduce methicillin-resistant S. aureus (MRSA) or methicillin-su

175 preoperative nares screens were positive for methicillin-resistant S. aureus (MRSA) or methicillin-su

176 ence determinant that may potentially impact methicillin-resistant S. aureus (MRSA) persistence in su

177 Methicillin-resistant S. aureus (MRSA) poses a significa

178 re, we studied a well-characterized clinical methicillin-resistant S. aureus (MRSA) strain (MW2), its

179 wed that the pknB gene (also called stk1) of methicillin-resistant S. aureus (MRSA) strain COL and th

180 tant S. aureus (VRSA) strain HIP11714 to the methicillin-resistant S. aureus (MRSA) strain COL for wh

181 Whole-genome analysis of a methicillin-resistant S. aureus (MRSA) strain USA500 rev

182 eta-lactam resistance in community-acquired, methicillin-resistant S. aureus (MRSA) strains but not i

183 The common USA300 methicillin-resistant S. aureus (MRSA) strains express a

184 We also demonstrate that clinically relevant methicillin-resistant S. aureus (MRSA) strains respond t

185 f recurring SSSI due to S. aureus, including methicillin-resistant S. aureus (MRSA) strains, despite

186 f arlRS does not play a role in autolysis of methicillin-resistant S. aureus (MRSA) strains, such as

187 ecurring SSSI due to S. aureus, particularly methicillin-resistant S. aureus (MRSA) strains, suggests

188 bidity are attributed to the rapid spread of methicillin-resistant S. aureus (MRSA) strains, which ar

189 nt mutant in the epidemic community-acquired methicillin-resistant S. aureus (MRSA) USA300 clone to s

190 he host response to pulmonary infection with methicillin-resistant S. aureus (MRSA) USA300.

191 Methicillin-resistant S. aureus (MRSA) was endemic in ho

192 the skin wounds were infected by S. aureus: methicillin-resistant S. aureus (MRSA) was recovered fro

193 Mortality due to methicillin-resistant S. aureus (MRSA) was significantly

194 FLGDEC (DD) that can recognize S. aureus and methicillin-resistant S. aureus (MRSA) was used as the r

195 trated that Staphylococcus aureus, including methicillin-resistant S. aureus (MRSA), and coagulase-ne

196 ively potentiates beta-lactam antibiotics in methicillin-resistant S. aureus (MRSA), and re-sensitize

197 a dramatic increase in community-associated methicillin-resistant S. aureus (MRSA), but recent repor

198 used by antibiotic-resistant strains such as methicillin-resistant S. aureus (MRSA), calls for explor

199 g resistant Staphylococcus aureus, including methicillin-resistant S. aureus (MRSA), has become a wor

200 ection with Staphylococcus aureus, including methicillin-resistant S. aureus (MRSA), is a serious con

201 microbes was tested with the same approach: methicillin-resistant S. aureus (MRSA), multidrug-resist

202 nasal swab which was analyzed for S. aureus, methicillin-resistant S. aureus (MRSA), multidrug-resist

203 sence of Staphylococcus aureus, specifically methicillin-resistant S. aureus (MRSA), on retail meat p

204 en, Staphylococcus aureus, and in particular methicillin-resistant S. aureus (MRSA), one of the leadi

205 MICs < 1 mug/mL were achieved against methicillin-resistant S. aureus (MRSA), S. pneumoniae, a

206 of antibiotic-resistant strains, designated methicillin-resistant S. aureus (MRSA), staphylococcal B

207 er baumannii (PDRAB), Staphylococcus aureus, methicillin-resistant S. aureus (MRSA), Streptococcus py

208 Outcomes included carriage of S. aureus, methicillin-resistant S. aureus (MRSA), tetracycline-res

209 al tests for the detection of mecC-harboring methicillin-resistant S. aureus (MRSA), which failed to

210 odstream infections (BSIs), particularly for methicillin-resistant S. aureus (MRSA).

211 concomitantly colonized with virulent USA300 methicillin-resistant S. aureus (MRSA).

212 ia caused by the USA300 community-associated methicillin-resistant S. aureus (MRSA).

213 /449 [66.4%]), of which 74.8% (223/298) were methicillin-resistant S. aureus (MRSA).

214 kage and inflammation caused by both HKSA or methicillin-resistant S. aureus (MRSA).

215 ence of antibiotic-resistant strains such as methicillin-resistant S. aureus (MRSA).

216 ents biofilm formation by S. epidermidis and methicillin-resistant S. aureus (MRSA).

217 ics, with the resultant strain designated as methicillin-resistant S. aureus (MRSA).

218 se infections caused by community-associated methicillin-resistant S. aureus (MRSA).

219 ed the mecA gene for PBP2a are designated as methicillin-resistant S. aureus (MRSA).

220 the most frequent invasive infection due to methicillin-resistant S. aureus (MRSA).

221 methicillin-susceptible S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA).

222 ainst S. aureus TMK and 2 mug/mL MIC against methicillin-resistant S. aureus (MRSA).

223 n and skin structure infection (SSSI) due to methicillin-resistant S. aureus (MRSA).

224 dmission (16.7%); 59 (5.3%) patients carried methicillin-resistant S. aureus (MRSA).

225 Conversely, methicillin-resistant S. aureus (MRSA; the drug resistan

226 ic wounds such as P.aeruginosa, S.aureus and Methicillin-resistant S.aureus (MRSA) are mediated via t

227 A total of 287 isolates (173 methicillin-resistant S. aureus [MRSA] and 114 methicill

228 hundred seventy-nine S. aureus isolates (125 methicillin-resistant S. aureus [MRSA] and 254 methicill

229 occus aureus collected from U.S. (53.8% were methicillin-resistant S. aureus [MRSA]) and Canadian (46

230 e emergence of antibiotic-resistant strains (methicillin-resistant S. aureus [MRSA]) has prompted res

231 141 methicillin-susceptible S. aureus and 89 methicillin-resistant S. aureus [MRSA]) were analyzed.

232 .1%) had zone sizes of </=17 mm (all 105 had methicillin-resistant S. aureus [MRSA]), 18 (6.5%) had z

233 ptible Staphylococcus aureus [MSSA] and 6.3% methicillin-resistant S. aureus [MRSA]), and hand carria

234 al centers included 59 patients with SaB (47 methicillin-resistant S. aureus [MRSA], 12 methicillin-s

235 entiates between methicillin-susceptible and methicillin-resistant S. aureus (MSSA and MRSA, respecti

236 the agr regulon in the community-associated methicillin-resistant S. aureus MW2 considerably differe

237 Methicillin-resistant S. aureus nasal carriage had a hig

238 ation vs. one of 171 (0.6%) subjects without methicillin-resistant S. aureus nasal colonization (p <

239 of interest were the prevalence estimate of methicillin-resistant S. aureus nasal colonization at ad

240 patients provided an estimated prevalence of methicillin-resistant S. aureus nasal colonization at ad

241 ccurred in seven of 29 (24.1%) subjects with methicillin-resistant S. aureus nasal colonization vs. o

242 recovered in 15 of 29 (51.7%) subjects with methicillin-resistant S. aureus nasal colonization vs. t

243 n be used to rapidly recognize patients with methicillin-resistant S. aureus nasal colonization who a

244 ng drinks like tea have been found to reduce methicillin-resistant S. aureus nasal colonization.

245 Overall 29 of 200 (14.5%) were found to have methicillin-resistant S. aureus nasal colonization.

246 l colonization vs. two of 171 (1.2%) without methicillin-resistant S. aureus nasal colonization.

247 pated transfer of vancomycin resistance to a methicillin-resistant S. aureus occurred in vivo by inte

248 Methicillin-resistant S. aureus occurred with similar fr

249 CAP was associated with an increased risk of methicillin-resistant S. aureus (odds ratio [OR], 4.72;

250 n-susceptible S. aureus was detected but not methicillin-resistant S. aureus or S. pyogenes from cell

251 nterval [CI], 2.24 to 92.55), infection with methicillin-resistant S. aureus (OR, 9.3; 95% CI, 1.45 t

252 XpressFISH assay, which detected 209 of 211 methicillin-resistant S. aureus organisms (sensitivity,

253 ceptible to oxacillin (oxacillin-susceptible methicillin-resistant S. aureus [OS-MRSA]).

254 specialized ICUs populations and reports on methicillin-resistant S. aureus outbreaks were excluded.

255 phylococcus aureus (p = 0.007), particularly methicillin-resistant S. aureus (p < 0.0001).

256 Methicillin-resistant S. aureus, P. aeruginosa, C. diffi

257 innate immune response in a murine model of methicillin-resistant S. aureus pneumonia.

258 tivity permits detection of genomic DNA from methicillin-resistant S. aureus positive blood cultures

259 s study calculates the cost-effectiveness of methicillin-resistant S aureus prevention strategies and

260 to determine if the implementation costs of methicillin-resistant S aureus prevention strategies are

261 itially inappropriate antibiotic therapy for methicillin-resistant S. aureus prolongs length of stay

262 showed a genetic similarity to PVL-positive, methicillin-resistant S. aureus (PVL-MRSA) strains, alth

263 episodes with 90-day follow-up, excluding 5 methicillin-resistant S. aureus SAB cases.

264 d "sporadic." The most prevalent lineage was methicillin-resistant S. aureus (SAL 4).

265 develop a murine model of community-acquired methicillin-resistant S. aureus SSTI (CA-MRSA SSTI) that

266 tailed description of a community-associated methicillin-resistant S. aureus ST80 orbital cellulitis

267 ntified patients admitted with nonnosocomial methicillin-resistant S. aureus sterile-site infections

268 itially inappropriate antibiotic therapy for methicillin-resistant S. aureus sterile-site infections

269 Methicillin-resistant S. aureus strain 301 (MRSA 301) or

270 ours, at which point they were infected with methicillin-resistant S. aureus strain AW7 via the endot

271 A USA300 community-associated methicillin-resistant S. aureus strain deficient in Rot

272 Also, inactivation of LyrA in a methicillin-resistant S. aureus strain did not precipita

273 n of the pbp2 gene did not block growth of a methicillin-resistant S. aureus strain expressing the ex

274 re found to be active against vancomycin and methicillin-resistant S. aureus strain with appreciable

275 nd in combination with the lux operon into a methicillin-resistant S. aureus strain.

276 Methicillin-resistant S aureus strains concordant with i

277 ecially highly pathogenic community-acquired methicillin-resistant S aureus strains, release high amo

278 l health threat because of the prevalence of methicillin-resistant S. aureus strains (MRSA).

279 hyococcus aureus and especially the epidemic methicillin-resistant S. aureus strains cause severe nec

280 Most methicillin-resistant S. aureus strains causing bacterem

281 ain MW2 (USA400 lineage) and other community methicillin-resistant S. aureus strains most commonly ca

282 ICab could be a valuable tool for detecting methicillin-resistant S. aureus strains that express eff

283 ar effects of PVL using community-associated methicillin-resistant S. aureus strains, we found no sig

284 athogenicity factors of community-associated methicillin-resistant S. aureus strains.

285 Newer agents active against methicillin-resistant S. aureus such as linezolid have b

286 m the nares of 6 of 32 infants surveyed in a methicillin-resistant S. aureus surveillance program, an

287 This review of the changing epidemiology of methicillin-resistant S. aureus, the emergence of vancom

288 on, the tibias of rabbits were infected with methicillin-resistant S. aureus to produce chronic osteo

289 Methicillin-resistant S. aureus treated with plicatamide

290 Community-acquired methicillin-resistant S. aureus used to be predominantly

291 tibiotic-resistant strains tested, including methicillin-resistant S. aureus, vancomycin-intermediate

292 nt S. aureus colonization as a predictor for methicillin-resistant S. aureus ventilator-associated pn

293 olonization in predicting the development of methicillin-resistant S. aureus ventilator-associated pn

294 Of the 388 patients, 37 (9.5%) had methicillin-resistant S. aureus ventilator-associated pn

295 Methicillin-resistant S aureus was recovered from sample

296 After we controlled for confounding factors, methicillin-resistant S. aureus was associated with the

297 A clinical isolate of methicillin-resistant S. aureus was killed by platelets

298 Methicillin-resistant S. aureus was not found by culture

299 Nasal cultures for methicillin-resistant S. aureus were performed on all su

300 reus, methicillin-susceptible S. aureus, and methicillin-resistant S. aureus with sensitivities of 10